Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edema.

@article{AlDhibi2009BilateralRF,
  title={Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edema.},
  author={Hassan A. Al-Dhibi and A O Khan},
  journal={Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus},
  year={2009},
  volume={13 4},
  pages={400-2}
}
Untreated cystoid macular edema (CME) is a major cause for visual loss in intermediate and posterior forms of uveitis. Conventional treatments for inflammatory CME include steroids, nonsteroidal antiinflammatory agents, and carbonic anhydrase inhibitors; however, not all patients respond, even after quieting of the uveitis. Intravitreal injection of bevacizumab, a monoclonal antibody to vascular endothelial growth factor, has recently been suggested as a short-term treatment for inflammatory… CONTINUE READING